David Erlinge
101 – 110 of 510
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
How much is good enough? : Insights from myocardial infarction incidence during COVID-19 pandemic
- Contribution to journal › Debate/Note/Editorial
-
Mark
Uninterrupted Oral Anticoagulant Therapy in Patients Undergoing Unplanned Percutaneous Coronary Intervention
- Contribution to journal › Article
-
Mark
Randomized comparison of early supplemental oxygen versus ambient air in patients with confirmed myocardial infarction : Sex-related outcomes from DETO2X-AMI
- Contribution to journal › Article
-
Mark
Sex-differences in circulating biomarkers during acute myocardial infarction : An analysis from the SWEDEHEART registry
- Contribution to journal › Article
-
Mark
Differences in biomarker concentrations and predictions of long-term outcome in patients with ST-elevation and non-ST-elevation myocardial infarction
- Contribution to journal › Article
-
Mark
A multicentre, prospective, randomised controlled trial to assess the safety and effectiveness of cooling as an adjunctive therapy to percutaneous intervention in patients with acute myocardial infarction : The COOL AMI EU Pivotal Trial
- Contribution to journal › Article
-
Mark
Pretreatment With P2Y12 Inhibitors in Patients With Chronic Coronary Syndrome Undergoing Percutaneous Coronary Intervention : A Report From the Swedish Coronary Angiography and Angioplasty Registry
- Contribution to journal › Article
-
Mark
Clinical impact of intraprocedural stent thrombosis during percutaneous coronary intervention in patients treated with potent p2y12 inhibitors -A validate-swedeheart substudy
- Contribution to journal › Article
-
Mark
Reply to Trimaille et al.
- Contribution to journal › Letter
-
Mark
Registry-based randomized clinical trials in cardiology : Opportunities and challenges
- Contribution to journal › Scientific review
